Search results for: 'bax inhibitor peptide negative control'
-
A8394 CHIR-124Target: FLT3|GSK-3|Chk|PDGFRSummary: Chk1 inhibitor,novel and potent
-
A8550 Telatinib (BAY 57-9352)Target: VEGFR|PDGFR|c-KitSummary: VEGFR-2/-3,PDGFR-β and c-Kit inhibitor
-
A8252 Nintedanib (BIBF 1120)3 CitationTarget: VEGFR|PDGFR|FGFRSummary: VEGFR/PDGFR/FGFR inhibitor
-
B5835 AZD2932Target: FLT3|VEGFR|PDGFR|c-KitSummary: inhibitor of VEGFR-2, PDGFRβ, Flt-3, and c-Kit
-
A8236 Regorafenib4 CitationTarget: Raf|VEGFR|PDGFR|c-Kit|RETSummary: Inhibitor of VEGFR/PDGFR/FGFR/mutant kit/RET/Raf-1
-
B7354 SU 16fTarget: PDGFRSummary: PDGFRβ inhibitor
-
A3750 Regorafenib hydrochlorideTarget: Raf|VEGFR|PDGFR|c-Kit|c-RETSummary: Tyrosine kinase inhibitor
-
B5954 Dasatinib MonohydrateTarget: PDGFR|c-Kit|Bcr-Abl|SrcSummary: Inhibitor of ABL, SRC, KIT, PDGFR, and other tyrosine kinases.
-
B5953 Dovitinib (TKI258) LactateTarget: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: Oral tyrosine kinase inhibitor (TKI) against FGFR1–3, VEGFR1–3, and platelet-derived growth factor receptor (PDGFR).